MaxCyte falls after $151.8M deal to buy Akron Bio for cash and stock
This is a summary aggregated from Seeking Alpha. Read the complete article on the original site:
Read full article at Seeking Alpha
Related stories
Swift Student Challenge expands contest to all Apple platforms
AppleInsider · 8 min ago
Gravity can reconnect like the sun's magnetic field, a fresh look at Einstein's equations reveals
Live Science · 8 min ago
The weight of gold: Inside surfing star John Florence's Olympic-sized decision
ESPN · 10 min ago
Most common players on eliminated teams from Week 9 in Yahoo Fantasy Death leagues — plus FAB waiver wire advice
Yahoo Sports · 11 min ago
Microsoft tumbles as Anthropic unveils office tools ahead of IPO
Seeking Alpha · 12 min ago
Mosaic raises $47m to build surgical machines that navigate blood vessels
NextWeb · 12 min ago